HSBC Downgrades Amgen to Hold, Lowers Price Target to $425
HSBC Downgrades Amgen to Hold, Lowers Price Target to $425
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day